Global Biosimilar and Follow-on Biologics Market to Reach USD 102.28 Billion by 2032, Expanding at 17.02% CAGR
Global Biosimilar and Follow-on Biologics Market to Reach USD 102.28 Billion by 2032, Expanding at 17.02% CAGR  The Global Biosimilar and Follow-on Biologics Market is entering a new phase of accelerated healthcare innovation, with the market valued at USD 34.04 Billion in 2025 and projected to reach nearly USD 102.28 Billion by 2032, registering a robust CAGR of 17.02% during...
0 Comments 0 Shares 269 Views 0 Reviews